Matinas Biopharma Holdings, Inc. Common Stock (MTNB)
Seasonality Analysis
Matinas Biopharma Holdings, Inc. Common Stock Annual Seasonality Statistics
Matinas Biopharma Holdings, Inc. Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 0.89% | Weak | |
| February | 3.01% | Weak | |
| March | -6.47% | Very Weak | |
| April | -1.67% | Very Weak | |
| May | -3.66% | Very Weak | |
| June | -5.60% | Very Weak | |
| July WORST | -8.82% | Very Weak | |
| August | 6.05% | Weak | |
| September BEST | 16.18% | Weak | |
| October | -4.95% | Very Weak | |
| November | 2.06% | Strong | |
| December | -0.24% | Weak |
Matinas Biopharma Holdings, Inc. Common Stock 2026 vs Historical Pattern
Matinas Biopharma Holdings, Inc. Common Stock Interactive Seasonality Chart
Matinas Biopharma Holdings, Inc. Common Stock Pattern Scanner
Matinas Biopharma Holdings, Inc. Common Stock Seasonal Historical Performance
About Matinas Biopharma Holdings, Inc. Common Stock (MTNB) Seasonality
Matinas Biopharma Holdings, Inc. Common Stock (MTNB) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, Matinas Biopharma Holdings, Inc. Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for Matinas Biopharma Holdings, Inc. Common Stock is historically September, with an average return of 16.18% and a win rate of 50%. Conversely, July tends to be the weakest month, averaging -8.82% return.
Looking at the full calendar year, Matinas Biopharma Holdings, Inc. Common Stock has an average annual return of -3.21% with an overall monthly win rate of 38.6%. Out of 12 months, 5 typically show positive average returns.
The seasonal pattern for Matinas Biopharma Holdings, Inc. Common Stock has a consistency score of 47.7 (Poor), based on 13 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
Matinas Biopharma Holdings, Inc. Common Stock Seasonality FAQ
What is the best month to buy Matinas Biopharma Holdings, Inc. Common Stock (MTNB)?
Historically, September has been the best month for Matinas Biopharma Holdings, Inc. Common Stock, with an average return of 16.18% and a win rate of 50%. However, past performance does not guarantee future results.
What is the worst month for Matinas Biopharma Holdings, Inc. Common Stock (MTNB)?
Based on historical data, July has been the weakest month for Matinas Biopharma Holdings, Inc. Common Stock, with an average return of -8.82%. This is a historical observation and does not guarantee future results.
How reliable is MTNB seasonality data?
The seasonality analysis for Matinas Biopharma Holdings, Inc. Common Stock is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use Matinas Biopharma Holdings, Inc. Common Stock seasonality in my trading?
Use Matinas Biopharma Holdings, Inc. Common Stock (MTNB) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.